A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous Histamine Dihydrochloride for Migraine Prophylaxis
Unknown status
AgoneX Biopharmaceuticals, Inc.
Phase 2
2015-09-01
This is a prospective multi-center, randomized, double-blind, two treatment period,
placebo-controlled study in subjects with migraine headache requiring prophylactic treatment.
The patients will be randomized to receive either histamine dihydrochloride sc or placebo
(matching vehicle only) sc for 16 weeks. The safety and efficacy outcome measures will be
assessed at selected dosing segments during the 16 week treatment phase and 4 weeks (week
20), 8 weeks (week 24) after the last Injection.
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous Histamine Dihydrochloride for Migraine Prophylaxis
Unknown status
BioHealthonomics Inc.
Phase 2
2015-09-01
This is a prospective multi-center, randomized, double-blind, two treatment period,
placebo-controlled study in subjects with migraine headache requiring prophylactic treatment.
The patients will be randomized to receive either histamine dihydrochloride sc or placebo
(matching vehicle only) sc for 16 weeks. The safety and efficacy outcome measures will be
assessed at selected dosing segments during the 16 week treatment phase and 4 weeks (week
20), 8 weeks (week 24) after the last Injection.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
